Imlunestrant with or without abemaciclib in advanced breast cancer (ABC): Safety analyses from the phase III EMBER-3 trial Meeting Abstract
| Authors: | O'Shaughnessy, J.; Bidard, F. C.; Neven, P.; Casalnuovo, M. L.; Aftimos, P. G.; Manich, C. S.; Harbeck, N.; Carey, L. A.; Curigliano, G.; García-Sáenz, J. A.; Fernández-Abad, M.; De Paula, L. C. L.; Park, Y. H.; Ozyilkan, O.; Munoz, M.; Formentini, S.; Barrett, E.; Cao, S. S.; Chawla, A.; Jhaveri, K. L. |
| Abstract Title: | Imlunestrant with or without abemaciclib in advanced breast cancer (ABC): Safety analyses from the phase III EMBER-3 trial |
| Meeting Title: | 2025 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 43 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2025 May 30-Jun 3 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2025-06-01 |
| Start Page: | 1060 |
| Language: | English |
| ACCESSION: | WOS:001509531000001 |
| DOI: | 10.1200/JCO.2025.43.16_suppl.1060 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
